Lung cancer is the most malignant human cancer worldwide, also with the highest incidence
rate. However, small-cell lung cancer (SCLC) accounts for 14% of all lung cancer cases …

This article discusses the studies on radiotherapy of high-grade gliomas published between
January 1, 2022, and June 30, 2022, with special reference to their molecular biology basis …

Simple Summary [68Ga] Ga-DOTA-SSTR PET imaging has recently been introduced in the
management of patients with brain tumors, mostly meningiomas and pituitary adenomas or …

Simple Summary Several advantages of molecular imaging, namely, positron emission
tomography (PET), have been already described in different settings of glioma management …

Breast cancer is one of the most common malignancies in women, with high morbidity and
mortality rates. In breast cancer, the use of novel radiopharmaceuticals in nuclear medicine …

PET/CT is revolutionising radiotherapy treatment planning in many cancer sites. While its
utility has been confirmed in some cancer sites, and is used in routine clinical practice, it is …

PET with amino acid tracers provides additional insight beyond MR imaging into the biology
of gliomas that can be used for initial diagnosis, delineation of tumor margins, planning of …

Simple Summary Positron emission tomography (PET), typically combined with computed
tomography (CT) has become a critical advanced imaging technique in oncology. With PET …

A new era in tumor classification, diagnosis, and prognostic evaluation has begun as a
consequence of recent developments in the molecular and genetic characterization of …

Imaging has a pivotal role in neuro-oncology for the management of primary and secondary
brain tumors. To this regard, positron emission tomography (PET) is increasingly used to …